Voltalia SA: Total number of shares and voting rights in the share capital as of March 31, 2021
Tweet
Share
E-mailTotal number of shares and voting rights in the share capital
as of March 31, 2021
(Articles L. 233-8 (II) of the French Commercial Code and 223-16 of the General Regulations of the French Financial Markets Authority)
| Date | Total number of shares in the capital | Number of theoretical voting rights | Number of exercisable voting rights |
| 03/31/2021 | 95 346 862 | 129 358 638 | 129 186 630 |
Next on the agenda: Q1 2021 revenues on April 21, 2021 (after market closing)
| About Voltalia (www.voltalia.com) | |
| Voltalia is an international player in the renewable energy sector. The Group produces and sells electricity generated from wind, solar, hydraulic, biomass and storage facilities that it owns and operates. Voltalia has generating capacity in operation and under construction of more than 1.4 GW and a portfolio of projects under development representing total capacity of 9.7 GW. Voltalia is also a service provider and supports its investor clients in renewable energy projects during all phases, from design to operation and maintenance. As a pioneer in the corporate market, Voltalia provides a global offer to private companies, ranging from the supply of green electricity and energy efficiency services to the local production of their own electricity. The Group has more than 1 130 employees and is present in 20 countries on 4 continents and is able to act worldwide on behalf of its clients. Voltalia is listed on the regulated market of Euronext Paris, compartment B (FR0011995588 – VLTSA) and is part of the Enternext Tech 40 and CAC Mid & Small indices. The Group is also included in the Gaïa-Index, an index for socially responsible midcaps. | |
| Voltalia Investor Relations: [email protected] T. +33 (0)1 81 70 37 00 | Actifin Press Contact: Jennifer Jullia [email protected] . T. +33 (0)1 56 88 11 11 |
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Streamline Health® Signs Second Enterprise Client
- ParaZero Integrates its Safety Technology into Draganfly’s Commander 3XL Drones for Home Hospital Delivery and Emergency Response
- Owlstone Medical Secures $6.5 Million to Support Development of Breath-based Diagnostics for Infectious Disease
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
